about
Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysisPrescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control studySystematic review of celecoxib for osteoarthritis and rheumatoid arthritis. Problems compromise review's validity.Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.Outcome trials of COX-2 selective inhibitors: global safety evaluation does not promise benefits.COX-2 inhibitors and the heart: are all coxibs the same?Risk of gastrointestinal effects with COX-2 inhibitors and NSAIDs: COX-2 inhibitors were thought of as a safe option.
P2860
Q24555478-4DFC8920-36FD-44A2-96CF-B4292A38C6C3Q24803974-2FA695F9-29AB-4599-94AA-3C0AE48EC075Q33813806-EAD8B9BF-E2D2-4C58-A68F-AD89565CCCFCQ34165468-ECA2BDE6-AC90-4F18-8BE4-50BCE0FD7B78Q35108309-3A6D6F08-1A05-4966-A6A3-5C7A069C65AFQ36441763-17C2BC5B-5CAC-478D-BE77-EAB7787E6404Q43141054-3CFF65F5-E7EC-4884-BCC4-B7604AD4A6F0
P2860
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Efficacy and safety of COX 2 inhibitors.
@en
Efficacy and safety of COX 2 inhibitors.
@nl
type
label
Efficacy and safety of COX 2 inhibitors.
@en
Efficacy and safety of COX 2 inhibitors.
@nl
prefLabel
Efficacy and safety of COX 2 inhibitors.
@en
Efficacy and safety of COX 2 inhibitors.
@nl
P2860
P356
P1433
P1476
Efficacy and safety of COX 2 inhibitors.
@en
P2093
Roger Jones
P2860
P304
P356
10.1136/BMJ.325.7365.607
P407
P577
2002-09-01T00:00:00Z